Pulse Explore Journal Club Debates Trending Researchers

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Prevalence of ROS1 fusion in Chinese patients with non‐small cell lung cancer | Synapse

November 23, 2018Open Access

View Full Paper

Prevalence of ROS1 fusion in Chinese patients with non‐small cell lung cancer

QZQing ZhangShanghai Jiao Tong University CWChunyan WuTongji University WDWei DingZhejiang University of Technology

Key Points

Key points are not available for this paper at this time.

Abstract

An overall ROS1 fusion frequency of 2.59% was confirmed in this study. ROS1 fusion was more prevalent among younger patients, never-smokers, and those at advanced node stages.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Zhang et al. (Fri,) studied this question.

synapsesocial.com/papers/69d72c193f906f6a06bef964 https://doi.org/https://doi.org/10.1111/1759-7714.12899

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The National Comprehensive Cancer Network1998 · 16,870 citations
2Cancer statistics in China, 20152016 · 18,019 citations
3A Rare Case of ROS1 and ALK Double Rearranged Non–Small Cell Lung Cancer2017 · 17 citations
4Oncogenic pathway signatures in human cancers as a guide to targeted therapies2005 · 2,072 citations
5ALK and ROS1 rearrangements, coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: a multicenter study of 732 cases2017 · 34 citations